Autism-associated brain differences can be observed in utero using MRI

Alpen Ortug1,2,3, Yurui Guo1, Henry A Feldman1

  • 1Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.

Insights

Autism spectrum disorder biomarkers may appear in the fetal period. Increased insular cortex volume in fetuses may predict future autism spectrum disorder development, aiding early identification.

Area of Science:

  • Neurodevelopmental disorders
  • Autism Spectrum Disorder (ASD) research
  • Fetal neuroimaging

Background:

  • Prenatal developmental changes are linked to autism spectrum disorders (ASD).
  • Early identification of anatomical predictors can advance understanding of ASD neurobiology.
  • This may lead to earlier and more effective ASD interventions.

Purpose of the Study:

  • To identify the earliest magnetic resonance imaging (MRI)-based regional volumetric biomarkers for ASD.
  • To investigate fetal brain development in relation to later ASD diagnosis.

Main Methods:

  • Retrospective analysis of clinical brain MRI data from fetuses.
  • Identification of prospective autism spectrum disorder cases based on later diagnosis.

Main Results:

  • MRI-based ASD biomarkers are detectable in the fetal period.
  • Increased insular cortex volume in fetuses shows promise as an early biomarker for ASD.
  • Other regional volume changes and hemispheric asymmetries may also be relevant.

Conclusions:

  • Fetal MRI can reveal biomarkers associated with future ASD development.
  • The insular cortex volume is a potential key prenatal indicator for ASD.
  • These findings support earlier identification and intervention strategies for autism spectrum disorders.

Related Concept Videos